Plumbline Life Sciences, Inc. (XKON:222670)
South Korea · Delayed Price · Currency is KRW 4,500.00
-170.00 (-3.64%)
At close: Feb 2, 2026
Plumbline Life Sciences Market Cap
Plumbline Life Sciences has a market cap or net worth of 18.15 billion as of February 2, 2026. Its market cap has increased by 49.91% in one year.
Market Cap
18.15B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,500.00
Market Cap Chart
Since April 5, 2017, Plumbline Life Sciences's market cap has increased from 17.58B to 18.15B, an increase of 3.23%. That is a compound annual growth rate of 0.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 18.15B | -11.76% |
| Dec 30, 2025 | 20.57B | 57.49% |
| Dec 30, 2024 | 13.06B | -23.38% |
| Dec 28, 2023 | 17.05B | 42.12% |
| Dec 29, 2022 | 11.99B | -45.37% |
| Dec 30, 2021 | 21.96B | -4.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J2KBIO | 48.83B |
| Aptamer Sciences | 45.93B |
| SCM Lifescience | 36.34B |
| Kainos Medicine | 35.56B |
| ADBiotech | 33.36B |
| Epibiotech | 32.30B |
| Eutilex.Co.,Ltd | 26.70B |
| Moogene Medi | 19.30B |